Black Diamond Therapeutics News

Black Diamond Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(19.0%)

Nov 15 02:34

Black Diamond Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Vestal Point Capital, LP(8.9%),Ryan Wilder(8.9%)

Nov 15 01:08

Black Diamond Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.2%)

Nov 9 03:20

Black Diamond Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5 20:06

Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 5 20:06

Black Diamond Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.2%)

Oct 25 02:06

Black Diamond Therapeutics | 8-K: Current report

Oct 8 05:14

Black Diamond Therapeutics | 8-K: Current report

Sep 23 19:13

Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali

Sep 21 04:34

Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Campbell Shannon

Sep 21 04:27

Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash

Sep 21 04:27

Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.

Aug 31 04:19

Black Diamond Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Ventures VI GP, L.P.(7.7%),Versant Ventures VI GP-GP, LLC(7.7%), etc.

Aug 9 04:50

Black Diamond Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6 19:08

Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 6 19:03

Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 1 04:21

Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 27 05:59

Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 17 04:53

Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 12 04:35

Black Diamond Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(18.9%)

Jul 11 02:18